ASX - By Stock
|
IVX |
Re:
Ann: Agreement with Major South Korean Pharma Group Hanlim
|
|
cashflowmonday
|
4 |
2.6K |
1 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
4
|
2.6K
|
1
|
|
ASX - By Stock
|
IVX |
Re:
Approval and Commencement of clinical Trials Australian Government Cancer.
|
|
cashflowmonday
|
2 |
1.8K |
0 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
2
|
1.8K
|
0
|
|
ASX - By Stock
|
IVX |
Re:
Ann: INV043 With ICI Therapy Achieved 80% Tumour Control For ASCC
|
|
cashflowmonday
|
19 |
9.8K |
1 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
19
|
9.8K
|
1
|
|
ASX - By Stock
|
IVX |
Re:
Ann: INV043 With ICI Therapy Achieved 80% Tumour Control For ASCC
|
|
cashflowmonday
|
19 |
9.8K |
3 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
19
|
9.8K
|
3
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Activities Report and Appendix 4C
|
|
cashflowmonday
|
5 |
2.0K |
0 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
5
|
2.0K
|
0
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Activities Report and Appendix 4C
|
|
cashflowmonday
|
5 |
2.0K |
0 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
5
|
2.0K
|
0
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Major Milestone towards Clinical Trials
|
|
cashflowmonday
|
14 |
7.9K |
0 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
14
|
7.9K
|
0
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Major Milestone towards Clinical Trials
|
|
cashflowmonday
|
14 |
7.9K |
3 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
14
|
7.9K
|
3
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Major Milestone towards Clinical Trials
|
|
cashflowmonday
|
14 |
7.9K |
2 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
14
|
7.9K
|
2
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
cashflowmonday
|
6 |
2.3K |
0 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
6
|
2.3K
|
0
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
cashflowmonday
|
6 |
2.3K |
1 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
6
|
2.3K
|
1
|
|
ASX - By Stock
|
IVX Biotech |
Re:
(RMW) Phase II Prostate Cancer Trial is being presented today
|
|
cashflowmonday
|
17 |
11K |
0 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
17
|
11K
|
0
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Photosoft Territory Expanded to South Korea for Cancer
|
|
cashflowmonday
|
13 |
4.4K |
3 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
13
|
4.4K
|
3
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Photosoft Territory Expanded to South Korea for Cancer
|
|
cashflowmonday
|
13 |
4.4K |
0 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
13
|
4.4K
|
0
|
|
ASX - By Stock
|
IVX Biotech |
Re:
(RMW) Phase II Prostate Cancer Trial is being presented today
|
|
cashflowmonday
|
17 |
11K |
2 |
06/09/23 |
06/09/23 |
ASX - By Stock
|
17
|
11K
|
2
|
|
ASX - By Stock
|
IVX Biotech |
Re:
(RMW) Phase II Prostate Cancer Trial is being presented today
|
|
cashflowmonday
|
17 |
11K |
0 |
06/09/23 |
06/09/23 |
ASX - By Stock
|
17
|
11K
|
0
|
|
ASX - By Stock
|
IVX Biotech |
Re:
(RMW) Phase II Prostate Cancer Trial is being presented today
|
|
cashflowmonday
|
17 |
11K |
3 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
17
|
11K
|
3
|
|
ASX - By Stock
|
IVX Biotech |
Re:
(RMW) Phase II Prostate Cancer Trial is being presented today
|
|
cashflowmonday
|
17 |
11K |
2 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
17
|
11K
|
2
|
|
ASX - By Stock
|
IVX Biotech |
Re:
Anti-Cancer Immune Response - PhotosoftTM technology
|
|
cashflowmonday
|
9 |
3.9K |
0 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
9
|
3.9K
|
0
|
|
ASX - By Stock
|
IVX Biotech |
Re:
Anti-Cancer Immune Response - PhotosoftTM technology
|
|
cashflowmonday
|
9 |
3.9K |
0 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
9
|
3.9K
|
0
|
|
ASX - By Stock
|
IVX Biotech |
Re:
Anti-Cancer Immune Response - PhotosoftTM technology
|
|
cashflowmonday
|
9 |
3.9K |
3 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
9
|
3.9K
|
3
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Photosoft Effective Against Superbugs and Other Pathogens
|
|
cashflowmonday
|
32 |
14K |
0 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
32
|
14K
|
0
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Invion completes spin-out of respiratory assets
|
|
cashflowmonday
|
13 |
7.8K |
0 |
30/06/23 |
30/06/23 |
ASX - By Stock
|
13
|
7.8K
|
0
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Invion completes spin-out of respiratory assets
|
|
cashflowmonday
|
13 |
7.8K |
1 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
13
|
7.8K
|
1
|
|
ASX - By Stock
|
IVX Biotech |
Re:
Anti-Cancer Immune Response - PhotosoftTM technology
|
|
cashflowmonday
|
9 |
3.9K |
2 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
9
|
3.9K
|
2
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Photosoft Effective Against Superbugs and Other Pathogens
|
|
cashflowmonday
|
32 |
14K |
1 |
26/06/23 |
26/06/23 |
ASX - By Stock
|
32
|
14K
|
1
|
|
ASX - By Stock
|
IVX |
Re:
IVXO
|
|
cashflowmonday
|
10 |
3.4K |
2 |
17/06/23 |
17/06/23 |
ASX - By Stock
|
10
|
3.4K
|
2
|
|
ASX - By Stock
|
IVX |
Re:
IVXO
|
|
cashflowmonday
|
10 |
3.4K |
4 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
10
|
3.4K
|
4
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Photosoft Effective Against Superbugs and Other Pathogens
|
|
cashflowmonday
|
32 |
14K |
1 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
32
|
14K
|
1
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Photosoft Effective Against Superbugs and Other Pathogens
|
|
cashflowmonday
|
32 |
14K |
0 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
32
|
14K
|
0
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Photosoft Effective Against Superbugs and Other Pathogens
|
|
cashflowmonday
|
32 |
14K |
1 |
13/05/23 |
13/05/23 |
ASX - By Stock
|
32
|
14K
|
1
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Photosoft Effective Against Superbugs and Other Pathogens
|
|
cashflowmonday
|
32 |
14K |
0 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
32
|
14K
|
0
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Photosoft Effective Against Superbugs and Other Pathogens
|
|
cashflowmonday
|
32 |
14K |
0 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
32
|
14K
|
0
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Photosoft Effective Against Superbugs and Other Pathogens
|
|
cashflowmonday
|
32 |
14K |
0 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
32
|
14K
|
0
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Photosoft Effective Against Superbugs and Other Pathogens
|
|
cashflowmonday
|
32 |
14K |
1 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
32
|
14K
|
1
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Activities Report and Appendix 4C
|
|
cashflowmonday
|
2 |
928 |
0 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
2
|
928
|
0
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Appendix 4D and Half Year Financial Report
|
|
cashflowmonday
|
17 |
7.1K |
0 |
12/03/23 |
12/03/23 |
ASX - By Stock
|
17
|
7.1K
|
0
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Appendix 4D and Half Year Financial Report
|
|
cashflowmonday
|
17 |
7.1K |
1 |
10/03/23 |
10/03/23 |
ASX - By Stock
|
17
|
7.1K
|
1
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Appendix 4D and Half Year Financial Report
|
|
cashflowmonday
|
17 |
7.1K |
4 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
17
|
7.1K
|
4
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Appendix 4D and Half Year Financial Report
|
|
cashflowmonday
|
17 |
7.1K |
2 |
07/03/23 |
07/03/23 |
ASX - By Stock
|
17
|
7.1K
|
2
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Appendix 4D and Half Year Financial Report
|
|
cashflowmonday
|
17 |
7.1K |
2 |
04/03/23 |
04/03/23 |
ASX - By Stock
|
17
|
7.1K
|
2
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Appendix 4D and Half Year Financial Report
|
|
cashflowmonday
|
17 |
7.1K |
2 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
17
|
7.1K
|
2
|
|
ASX - By Stock
|
IVX |
Re:
CEO Renumeration
|
|
cashflowmonday
|
47 |
19K |
2 |
09/02/23 |
09/02/23 |
ASX - By Stock
|
47
|
19K
|
2
|
|
ASX - By Stock
|
IVX |
Re:
CEO Renumeration
|
|
cashflowmonday
|
47 |
19K |
0 |
08/02/23 |
08/02/23 |
ASX - By Stock
|
47
|
19K
|
0
|
|
ASX - By Stock
|
IVX |
Re:
CEO Renumeration
|
|
cashflowmonday
|
47 |
19K |
1 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
47
|
19K
|
1
|
|
ASX - By Stock
|
IVX |
Re:
CEO Renumeration
|
|
cashflowmonday
|
47 |
19K |
2 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
47
|
19K
|
2
|
|
ASX - By Stock
|
IVX |
Re:
CEO Renumeration
|
|
cashflowmonday
|
47 |
19K |
1 |
24/01/23 |
24/01/23 |
ASX - By Stock
|
47
|
19K
|
1
|
|
ASX - By Stock
|
IVX |
Re:
CEO Renumeration
|
|
cashflowmonday
|
47 |
19K |
2 |
20/01/23 |
20/01/23 |
ASX - By Stock
|
47
|
19K
|
2
|
|
ASX - By Stock
|
IVX |
Re:
CEO Renumeration
|
|
cashflowmonday
|
47 |
19K |
1 |
07/01/23 |
07/01/23 |
ASX - By Stock
|
47
|
19K
|
1
|
|
ASX - By Stock
|
IVX |
Re:
CEO Renumeration
|
|
cashflowmonday
|
47 |
19K |
3 |
14/12/22 |
14/12/22 |
ASX - By Stock
|
47
|
19K
|
3
|
|